The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal Hypertension

Publisher： John Wiley & Sons Inc

E-ISSN： 1613-6829|11|19|2291-2304

ISSN： 1613-6810

Source： SMALL, Vol.11, Iss.19, 2015-05, pp. : 2291-2304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Noncirrhotic portal hypertension: An overview

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 3, 2015-09 ,pp. : 72-74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Noncirrhotic portal hypertension: An overview

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 2046-2484, Iss. 3, 2015-09 ,pp. : 72-74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis

By  

NMR IN BIOMEDICINE (ELECTRONIC), Vol. 28, Iss. 12, 2015-12 ,pp. : 1716-1725

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgical management of noncirrhotic portal hypertension

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 5, 2015-05 ,pp. : 112-115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Noncirrhotic portal hypertension in the pediatric population

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 5, 2015-05 ,pp. : 116-119

John Wiley & Sons Inc

Access to resources Recommend Favorite